ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
103 hedge funds and large institutions have $176M invested in Antares Pharma, Inc. in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
5% less capital invested
Capital invested by funds: $185M → $176M (-$9.32M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
103
Holding in Top 10
1
Calls
$333K
Puts
$356K
Top Buyers
| 1 | +$9.44M | |
| 2 | +$1.97M | |
| 3 | +$1.31M | |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$1.15M |
| 5 |
Two Sigma Investments
New York
|
+$1.12M |
Top Sellers
| 1 | -$9.28M | |
| 2 | -$5.18M | |
| 3 | -$4.86M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$3.05M |
| 5 |
Renaissance Technologies
New York
|
-$2.2M |